Literature DB >> 35146226

If at first you don't succeed… a complicated course of endoscopic reversal of a gastric bypass.

Kevin D Platt1, Oliver A Varban2, Allison R Schulman1,2.   

Abstract

Video 1.If at first you don't succeed… A complicated course of endoscopic reversal of a gastric bypass.
© 2022 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc.

Entities:  

Keywords:  RYGB, Roux-en-Y gastric bypass

Year:  2021        PMID: 35146226      PMCID: PMC8819522          DOI: 10.1016/j.vgie.2021.11.003

Source DB:  PubMed          Journal:  VideoGIE        ISSN: 2468-4481


Marginal ulcer remains a common adverse event after Roux-en-Y gastric bypass (RYGB). Despite treatment with antisecretory therapy, up to a third of patients with recalcitrant ulcers may require surgical revision.1, 2, 3, 4 In suboptimal surgical candidates or in patients who have failed attempts at surgical intervention, endoscopic techniques may be a preferable or required approach. Case reports have described uncomplicated endoscopic bypass reversal to treat refractory marginal ulcers. Here, we describe a more complicated, protracted case of a refractory marginal ulceration requiring endoscopic reversal, highlighting the potential for an oscillating, yet salvageable, approach (Video 1, available online at www.giejournal.org). A 41-year-old woman with a distant history of open RYGB requiring a complex surgical revision re-presented several years later with abdominal pain, vomiting, and failure to thrive. The patient had an extensive evaluation at outside institution, including numerous endoscopic procedures without a clear anatomic cause, and she was ultimately taken to the operating room for reversal of her bypass. This procedure was aborted because of significant adhesions and was also complicated by considerable bleeding, requiring reoperation. Since that time, symptoms progressed. She underwent EGD, which was notable for stenosis of the gastrojejunal anastomosis as well as a marginal ulcer on the jejunal aspect (Fig. 1). Serial balloon dilations were performed; however, symptoms persisted, ultimately requiring enteral tube feeding.
Figure 1

Stenosis of the gastrojejunal anastomosis with deeply cratered marginal ulceration on jejunal aspect (arrows) (A) visualized on closer inspection (B).

Stenosis of the gastrojejunal anastomosis with deeply cratered marginal ulceration on jejunal aspect (arrows) (A) visualized on closer inspection (B). Her case was presented at a multidisciplinary conference. Given the inability to reverse her RYGB surgically, the decision was made to proceed with endoscopic reversal. The gastric remnant was identified and accessed endosonographically (Fig. 2). A 20- × 10-mm electrocautery enhanced lumen-apposing metal stent was successfully deployed to reconstitute the connection between her pouch and remnant stomach (Fig. 3). After placement, the stent was dilated with a hydrostatic balloon, at which point significant bleeding was visualized. Despite endoscopic efforts, urgent angiography was ultimately required. Active extravasation was seen from a small branch of the left gastric artery, and coiling was successful.
Figure 2

EUS-guided contrast injection following access of the gastric remnant in preparation for lumen-apposing metal stent deployment (A), also visualized on fluoroscopy (B).

Figure 3

Endoscopic (A) and fluoroscopic (B) images after deployment of a lumen-apposing metal stent to reconstitute connection between gastric pouch and remnant.

EUS-guided contrast injection following access of the gastric remnant in preparation for lumen-apposing metal stent deployment (A), also visualized on fluoroscopy (B). Endoscopic (A) and fluoroscopic (B) images after deployment of a lumen-apposing metal stent to reconstitute connection between gastric pouch and remnant. The patient ultimately recovered, and endoscopic reversal was completed by closure of the gastrojejunal anastomosis with suturing (Fig. 4). Unfortunately, several weeks later, her pain recurred. EGD revealed a large pouch ulcer due to ischemia from prior embolization (Fig. 5). Repeat endoscopic suturing was performed to oversew the ulcer.
Figure 4

Completion of Roux-en-Y gastric bypass reversal with endoscopic suturing closure of the gastrojejunal anastomosis.

Figure 5

Recurrent large marginal ulceration following embolization of a branch of the left gastric artery.

Completion of Roux-en-Y gastric bypass reversal with endoscopic suturing closure of the gastrojejunal anastomosis. Recurrent large marginal ulceration following embolization of a branch of the left gastric artery. Several months later, the patient represented with acute pain and vomiting. EGD revealed migration of the lumen-apposing metal stent into the gastric remnant, and this was removed. A longer, fully covered self-expandable metal stent was placed and fixated (Fig. 6). There was evidence of recurrent marginal ulceration, which was re-treated with endoscopic suturing.
Figure 6

Fluoroscopic image before (A) and after (B) deployment of fully covered self-expandable metal stent to maintain fistulous connection between the gastric pouch and remnant.

Fluoroscopic image before (A) and after (B) deployment of fully covered self-expandable metal stent to maintain fistulous connection between the gastric pouch and remnant. The patient felt well for several months, until she again presented with obstructive symptoms. Repeat EGD revealed migration of the fully covered self-expandable metal stent. Given the chronicity and complete epithelization of the fistulous tract, the decision was made not to replace the stent. An upper GI series 4 weeks later demonstrated a patent gastro-gastric fistula (Fig. 7). At 6 months of follow-up, she continues to see our surgical colleagues regularly to discuss next steps or definitive operative intervention should symptoms recur.
Figure 7

Endoscopic (A) and upper GI series (B) demonstrating patent gastro-gastric fistula.

Endoscopic (A) and upper GI series (B) demonstrating patent gastro-gastric fistula. This video highlights the complicated, yet salvageable, course of an endoscopic reversal of RYGB for recalcitrant marginal ulcer after failure of surgical intervention. As demonstrated in this case, multiple stent placements and repeated endoscopic suturing may be required to achieve this successful outcome. Furthermore, should future surgical interventions be entertained, endoscopic management may provide temporization and nutritional optimization during a time at which operative options are suboptimal.

Disclosure

Dr Varban has salary support for participation and leadership in collaborative quality improvement initiatives from Blue Cross Blue Shield of Michigan. Dr Schulman is a consultant for Apollo Endosurgery, Boston Scientific, MicroTech, Olympus, and GI Dynamics. All other authors disclosed no financial relationships.
  5 in total

1.  Incidence and Prognostic Factors for the Development of Symptomatic and Asymptomatic Marginal Ulcers After Roux-en-Y Gastric Bypass Procedures.

Authors:  Julian Süsstrunk; Lara Wartmann; Diana Mattiello; Thomas Köstler; Urs Zingg
Journal:  Obes Surg       Date:  2021-03-24       Impact factor: 4.129

2.  Marginal ulceration following Roux-en-Y gastric bypass: risk factors for ulcer development, recurrence and need for revisional surgery.

Authors:  Adam Di Palma; Benjamin Liu; Azusa Maeda; Mehran Anvari; Timothy Jackson; Allan Okrainec
Journal:  Surg Endosc       Date:  2020-05-18       Impact factor: 4.584

3.  Endoscopic reversal of Roux-en-Y anatomy for the treatment of recurrent marginal ulceration.

Authors:  Veeravich Jaruvongvanich; Reem Matar; Daniel B Maselli; Andrew C Storm; Barham K Abu Dayyeh
Journal:  VideoGIE       Date:  2020-05-14

4.  Management and treatment outcomes of marginal ulcers after Roux-en-Y gastric bypass at a single high volume bariatric center.

Authors:  Rena C Moon; Andre F Teixeira; Michael Goldbach; Muhammad A Jawad
Journal:  Surg Obes Relat Dis       Date:  2013-10-11       Impact factor: 4.734

5.  Revisional operations for marginal ulcer after Roux-en-Y gastric bypass.

Authors:  Rohit A Patel; Robert E Brolin; Alok Gandhi
Journal:  Surg Obes Relat Dis       Date:  2008-11-06       Impact factor: 4.734

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.